|
|
|
Antimicrobial Agents and Chemotherapy, September 2004, p . 3618-3620, Vol . 48, No . 9 Colonization with Extraintestinal Pathogenic Escherichia coli among Nursing Home Residents and Its Relationship to Fluoroquinolone ResistanceJoel N . Maslow,1,2* Ebbing Lautenbach,2,3,4,5 Thomas Glaze,1 Warren Bilker,3,4,5 and James R . Johnson6 Section of Infectious Diseases, Veterans Affairs Medical Center,1 Division of Infectious Diseases,2 Center for Clinical Epidemiology and Biostatistics,3 Department of Biostatistics and Epidemiology,4 Center for Education and Research on Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania,5 Mucosal and Vaccine Research Center, Veterans Affairs Medical Center, and Department of Medicine, University of Minnesota, Minneapolis, Minnesota6 Received 15 December 2003/ Returned for modification 5 April 2004/ Accepted 25 May 2004
Antimicrobial resistance among GNB is an increasing problem among hospitalized and ambulatory patients (2) and residents in NHs (16) . Resistance to fluroquinolones (FQs), commonly prescribed oral agents, is also an increasing problem, including for E . coli (7-9) . Since the fecal flora is the presumed reservoir from which extraintestinal infection isolates arise, we studied whether NH residents manifest high rates of fecal carriage of ExPEC and, if present, whether they are FQ resistant (FQR) . Subjects were prospectively recruited at a 240-bed Veterans Affairs NH . The demographic mix is 50% minority and 1% female, with an average age of 75 years . Informed consent was obtained from the resident's legal guardian if the patient was cognitively impaired . The study was reviewed and approved by the facility Institutional Review Board . Between March and July 2002, 77 patients were approached for participation: 60 provided informed consent and were enrolled . Five subjects died or were discharged prior to the first sample collection . Rectal swabs were obtained at the time of recruitment and inoculated onto MacConkey agar without antimicrobial additives (nonselective medium) . Twenty-five lactose-positive colonies (as available) were arbitrarily selected and inoculated onto nonselective medium and MacConkey agar containing either 8-µg/ml ofloxacin or 1-µg/ml ceftazidime . Antimicrobial susceptibilities and confirmation of species as E . coli were performed by automated testing with the Vitek GNI card (BioMerieux, Hazelwood, Mo.) . Expression of extended-spectrum ß-lactamases (ESBLs) was determined by double-disk diffusion testing . The stools from six subjects did not yield E . coli . Thus, swabs from 49 subjects yielded E . coli and were further analyzed . FQR E . coli (FQREC) strains were detected in samples from 25 (51%) subjects; for 11 subjects, all colonies represented FQREC . ESBL expression was detected for only a single strain of FQREC .
Endonuclease analysis of XbaI macrorestriction fragments was performed by pulsed-field gel electrophoresis (PFGE) as described previously (11) . Clonal relationships were as defined by Tenover et al . (14) . PFGE was performed for all study isolates and yielded a single strain of E . coli for 27 (55%) of the subjects . Twenty-two samples (45%) yielded
For each patient, one isolate of each clonal type was subjected to phylogenetic and virulence factor analysis . Isolates were assigned to one of four phylogenetic groups (A, B1, B2, and D) by a triplex PCR-based method (3) . Isolates were screened for five key virulence markers: i.e., papA and papC (P fimbriae), sfa/foc (S and F1C fimbriae), afa/dra (DR adhesin), iutA (aerobactin), and kpsII (group 2 capsule) and were defined as ExPEC if positive for
In this study, we sought to determine whether the increase risk of urinary tract and bloodstream infection among NH residents was due to increased fecal carriage of virulent strains of E . coli, i.e., ExPEC . Additionally, since there are data suggesting that antimicrobial resistance is problematic in this population, we sought to determine whether NH residents frequently carry FQREC and whether such organisms represent ExPEC . ExPEC strains were observed to colonize the majority (54%) of study subjects, of which the majority represented clonal group B2-2 and carried iutA and kpsII . In contrast, adhesins and hemolysin, virulence factors classically associated with bacteremia and pyelonephritis (10), were detected in a minority of isolates (15%) from 22.4% subjects, a result similar to those from prior studies of normal fecal flora (1, 6, 13), which suggests that carriage of adhesin-positive strains was not spread within the NH population . One study reported an inverse relationship between the presence of cnf1 and hly (hemolysin) to nalidixic acid resistance (15) . In this study, the presence of aerobactin (aer) correlated with FQR, while sat and adhesins correlated with an isolate being FQS . No other virulence factor or group of virulence factors was significantly associated with FQR, although conclusions are limited by the small sample size . The increased prevalence of iutA- and kpsII-positive (and adhesin-negative) strains has unknown clinical ramifications, primarily since isolates of E . coli causing UTIs and bloodstream infections typically express adhesins and/or hemolysin (10) . An unanswered question is whether the presence of iutA- and kpsII-positive strains may increase the risk for future infectious events . In summary, while adhesin-positive strains are uncommon in NH residents, FQR ExPEC were frequently observed . Since the subjects were from a single Veterans Affairs NH, our study may not be applicable to all NH populations . The clinical importance of adhesin-negative isolates of FQR-ExPEC remains to be determined .
Sara Jane Brown and Kristin Owens are acknowledged for technical assistance . Edna Schwab and Ann Farrell are acknowledged for administrative assistance and many helpful discussions .
What Is Activated Sludge?,
What Is Salmonella?,
What Is Anthrax?,
What Is Pcr?,
What Is Bioremediation?,
r,
Microbe,
i,
Microbes,
e,
Bacterium,
c,
Microorganism,
i,
Bacteria,
e,
Rhizobacter,
i,
Microorganisms,
n,
Antimicrobial,
o,
Antimicrobial,
a,
Neisseria,
c,
Bifidobacterium,
a,
S. cerevisiae,
c,
Antibiotics,
c,
Antimicrobial,
r,
S. cerevisiae,
c,
Antibiotics,
o,
Escherichia coli,
i,
Microbial,
n,
Staphylococcus aureus,
s,
Penicillin,
i,
Botulism,
o,
MIC,
c,
Escherichia coli,
a,
Staphylococcus,
n,
Klebsiella,
e,
Minimal inhibiting concentration
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||